Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medicines Co (NASDAQ:MDCO)

50.03
Delayed Data
As of Mar 29
 -0.99 / -1.94%
Today’s Change
29.48
Today|||52-Week Range
55.28
+47.41%
Year-to-Date
Alnylam's LDL-Lowering Drug Positive in Phase II Study
Mar 20 / Zacks.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content